Evan Tzanis

3.8k total citations
68 papers, 1.6k citations indexed

About

Evan Tzanis is a scholar working on Pharmacology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Evan Tzanis has authored 68 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 16 papers in Infectious Diseases and 16 papers in Molecular Medicine. Recurrent topics in Evan Tzanis's work include Antibiotic Resistance in Bacteria (16 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). Evan Tzanis is often cited by papers focused on Antibiotic Resistance in Bacteria (16 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). Evan Tzanis collaborates with scholars based in United States, United Kingdom and Romania. Evan Tzanis's co-authors include Amy Manley, Lynne Garrity-Ryan, Judith N. Steenbergen, Surya Chitra, Paul C. McGovern, Stephen Villano, Paul B. Eckburg, Anita Das, Evan Loh and B. Randazzo and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Communications.

In The Last Decade

Evan Tzanis

64 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evan Tzanis United States	23	418	392	380	350	217	68	1.6k
Amy Manley United States	15	459 1.1×	327 0.8×	341 0.9×	313 0.9×	83 0.4×	28	1.1k
Michael P. Habib United States	24	141 0.3×	557 1.4×	72 0.2×	284 0.8×	137 0.6×	54	2.0k
Alfonso del Arco Spain	24	98 0.2×	488 1.2×	122 0.3×	413 1.2×	168 0.8×	91	2.0k
Phil Wiffen United Kingdom	8	289 0.7×	176 0.4×	114 0.3×	200 0.6×	105 0.5×	39	1.4k
Hiroyuki Suematsu Japan	24	139 0.3×	496 1.3×	188 0.5×	327 0.9×	239 1.1×	147	1.7k
Mark H. Gotfried United States	34	1.2k 2.8×	1.3k 3.3×	988 2.6×	441 1.3×	68 0.3×	87	3.4k
P Léophonte France	20	198 0.5×	877 2.2×	147 0.4×	129 0.4×	52 0.2×	97	1.4k
Stephen Brunton United States	22	189 0.5×	191 0.5×	37 0.1×	55 0.2×	104 0.5×	108	1.5k
Virginia Pomar Spain	20	173 0.4×	382 1.0×	315 0.8×	328 0.9×	108 0.5×	43	1.2k
Patrick Lebecque Belgium	31	122 0.3×	367 0.9×	344 0.9×	163 0.5×	60 0.3×	99	3.0k

Countries citing papers authored by Evan Tzanis

Since Specialization

Citations

This map shows the geographic impact of Evan Tzanis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Tzanis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Tzanis more than expected).

Fields of papers citing papers by Evan Tzanis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Tzanis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Tzanis. The network helps show where Evan Tzanis may publish in the future.

Co-authorship network of co-authors of Evan Tzanis

This figure shows the co-authorship network connecting the top 25 collaborators of Evan Tzanis. A scholar is included among the top collaborators of Evan Tzanis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan Tzanis. Evan Tzanis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lakota, Elizabeth A., Sujata M. Bhavnani, Lawrence V. Friedrich, et al.. (2023). Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics. Antimicrobial Agents and Chemotherapy. 67(4). e0239721–e0239721. 6 indexed citations

Torres, Antoni, Lynne Garrity-Ryan, Judith N. Steenbergen, et al.. (2021). Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia. International Journal of Infectious Diseases. 104. 501–509. 11 indexed citations

Hunt, Thomas L., Evan Tzanis, Stephen A. Bai, et al.. (2020). The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study. European Journal of Drug Metabolism and Pharmacokinetics. 46(1). 85–92. 16 indexed citations

Lewis, Myles, Darren Plant, Nisha Nair, et al.. (2020). Investigation of genetically regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between IL18RAP expression and treatment response. Annals of the Rheumatic Diseases. 79(11). 1446–1452. 12 indexed citations

Fung, Kenneth, Julia Ramírez, Helen R. Warren, et al.. (2019). Genome-wide association study identifies loci for arterial stiffness index in 127,121 UK Biobank participants. Scientific Reports. 9(1). 9143–9143. 31 indexed citations

O’Riordan, William, Lynne Garrity-Ryan, Anita Das, et al.. (2019). Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial. The Lancet Infectious Diseases. 19(10). 1080–1090. 73 indexed citations

Ramírez, Julio A., Evan Tzanis, Robert Noble, et al.. (2019). Early Clinical Response in Community-acquired Bacterial Pneumonia: From Clinical Endpoint to Clinical Practice. Clinical Infectious Diseases. 69(Supplement_1). S33–S39. 10 indexed citations

Ramírez, Julia, Stefan van Duijvenboden, Ιωάννα Ντάλλα, et al.. (2018). Thirty loci identified for heart rate response to exercise and recovery implicate autonomic nervous system. Nature Communications. 9(1). 1947–1947. 54 indexed citations

Plant, Darren, John Taylor, Marco Colombo, et al.. (2018). Prediction of treatment response in rheumatoid arthritis patients using genome‐wide SNP data. Genetic Epidemiology. 42(8). 754–771. 16 indexed citations

10.

Opal, Steven M., Thomas M. File, Tom van der Poll, et al.. (2018). 1374. Integrated Safety Summary of Omadacycline: A Novel Aminomethylcycline Antibiotic. Open Forum Infectious Diseases. 5(suppl_1). S421–S421. 4 indexed citations

11.

Darpö, Börje, Evan Tzanis, Lynne Garrity-Ryan, et al.. (2017). Cardiac Safety of Omadacycline in the IV/oral Phase 3 Acute Bacterial Skin and Skin Structure Infection (ABSSSI) and in the IV/oral Phase 3 Community-acquired Bacterial Pneumonia (CABP) Studies. Open Forum Infectious Diseases. 4(suppl_1). S544–S545. 4 indexed citations

12.

Rauck, Richard, et al.. (2015). Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain. Postgraduate Medicine. 128(1). 1–11. 42 indexed citations

13.

Xiang, Qinfang, et al.. (2015). (439) Efficacy and tolerability of BEMA buprenorphine in opioid-naive patients with moderate-to-severe chronic low back pain: primary results from a phase 3, enriched-enrollment, randomized withdrawal study. Journal of Pain. 16(4). S85–S85. 1 indexed citations

14.

Iyer, Shrividya, B. Randazzo, Evan Tzanis, et al.. (2011). Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms. Value in Health. 14(1). 177–183. 36 indexed citations

15.

Michna, Edward, E. Richard Blonsky, Seth L. Schulman, et al.. (2011). Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Patients With Chronic, Nonmalignant Pain: A Randomized Controlled Study. Journal of Pain. 12(5). 554–562. 118 indexed citations

16.

Michna, Edward, et al.. (2011). The long-term efficacy of subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic nonmalignant pain. Journal of Pain. 12(4). P70–P70. 4 indexed citations

17.

Randazzo, B., et al.. (2010). S1049 Characteristics of Gastrointestinal Adverse Events in Patients With Opioid-Induced Constipation and Chronic Non-Malignant Pain Treated With Subcutaneous Methylnaltrexone. Gastroenterology. 138(5). S–167.

18.

Liebowitz, Michael R., Gregory M. Asnis, Richard M. Mangano, & Evan Tzanis. (2009). A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic Disorder. The Journal of Clinical Psychiatry. 70(4). 550–561. 30 indexed citations

19.

Pollack, Mark H., Richard M. Mangano, Richard Entsuah, Evan Tzanis, & Naomi M. Simon. (2007). A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology. 194(2). 233–242. 47 indexed citations

20.

Pollack, Mark H., Ulla Lepola, Hannu Koponen, et al.. (2006). A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depression and Anxiety. 24(1). 1–14. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact